Rates of multiple myeloma (MM), the second most common blood cancer in the United States, are increasing and are twice as ...

Rates of multiple myeloma (MM), the second most common blood cancer in the United States, are increasing and are twice as ...

A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising ...

The benefits of early detection are clear: The earlier that cancer is diagnosed, the greater the chance of successful treatment and survival for the patient,1,2 and the more directed and efficient ...

Researchers at the University of Southampton have developed a promising new way to bolster the body's immune system response ...

Some claim the new multi-cancer detection tests will “revolutionize” cancer screening. Others fear the “worried well” will succumb to slick marketing and subpar tests and overwhelm both primary care ...

A new multi-pronged antibody design could help immune cells receive stronger activation signals against cancer. Researchers ...

MADISON, Wis., September 10, 2025 — Exact Sciences Corp. (Nasdaq: EXAS), a leader in cancer diagnostics, today announced the launch of the Cancerguard™ test, a new multi-cancer early detection (MCED) ...

Galleri is a blood test that aims to detect over 50 types of cancer early. It analyzes cell-free DNA (cfDNA) and methylation patterns to identify potential cancer signals. The test is intended for ...

Cancer screening tests are used to check for cancer or signs of cancer risk before a person has symptoms. There are two kinds of benefits from cancer screening tests: detection of abnormal cells that ...